Drug intelligence / Profile preview

phosphoramidon

Development stage
Unknown
Lead developer
Streptomyces tanashiensis
Modality
Small Molecules, Peptides
01

Overview

Phosphoramidon is a small molecule dipeptide inhibitor derived from the bacterium Streptomyces tanashiensis. It acts as a potent and reversible inhibitor of several zinc metallopeptidases including neprilysin (neutral endopeptidase 24.11), neprilysin 2, thermolysin, and endothelin-converting enzyme (ECE-1). By inhibiting these enzymes—especially neprilysin—it prevents the degradation of various bioactive peptides such as bradykinin and enkephalins. Phosphoramidon is widely used as a biochemical tool in research to study peptidase function and peptide metabolism but is not approved for clinical use[1][2][3][6][8].

Other names
phosphoramidon disodium saltN-(α-Rhamnopyranosyloxyhydroxyphosphinyl)-L-leucyl-L-tryptophanPhosporamidonPhosphramidon
02

Targets

TLN1 (Thermolysin)NEP (Neutral Endopeptidase)ECE1 (Endothelin-converting enzyme 1)ACE (Angiotensin Converting Enzyme)

Beyond the preview

Go deeper on phosphoramidon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phosphoramidon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call